The PhRMA Foundation seeks transformative, multi-stakeholder-driven solutions to address challenges in assessing the value of medicines and health care services to improve patient outcomes and reduce inefficiency. 
http://www.phrmafoundation.org/2018-awards/value-assessment-initiative/r...
deadline extended to July 15, 2020.

There are a number of limitations of the data sources, methodologies and measures applied in value assessment. For example, there is increased recognition that commonly used measures of health fail to capture important elements of value. Additionally, summary measures do not address heterogeneity in preferences and existing data sources do not allow for complete capture of patient-level information or preferred outcomes.
Example topics may include, but are not limited to:

• Measurement and reporting of value elements
• Frameworks for value assessment
• Selection and reporting of study populations
• Collection and measurement of patient-centered outcomes
• Heterogeneity of patient preferences
• Value element aggregation techniques
• Uncertainty in model parameters or structures
• Incorporation of real-world data
• Value from different stakeholder perspectives
• Ethical considerations